Daewoong awarded "Chang Young-sil Prize" for Co-Enzyme Q10.

Published: 2005-09-06 06:56:00

Updated: 2005-09-06 06:56:00

Daewoong was awarded "Chang Young-sil Prize" for the first development of "Daewoong Co-enzyme Q10" in Korea by the Ministry of Science and Technology under the auspice of the Korea Industrial Technology Association.

The development was made by Dr. Choi Soo-jin of Daewoong and his colleagues t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK